Docteur Gilbert Glady
Dr. Gilbert Glady is the creator of Bio Immuno(G)enetic Medicine, founder and president of the European Association of Bio Immuno(G)enetic Medicine.
Dr. Gilbert Glady dedicates himself both to clinical practice in his office and to scientific research, particularly in the formulation of new regulatory remedies.
In collaboration with a team of training physicians, he supervises the teaching of BI(G)MED in several European countries: Belgium, France, Germany, Austria, Spain, and Portugal.
Dr. Glady is the author of several scientific publications on the topic of nanobiotherapy. Several journals also regularly call upon him to evaluate as a “Reviewer” the quality of articles submitted for publication, particularly those dealing with epigenetics.
With his team, he participates in numerous international scientific and medical conferences.
Dr. Gilbert Glady’s journey: from oncohematology to BI(G)MED
Medical training and first steps
A graduate of the Faculty of Medicine at the University of Strasbourg in 1977, Dr. Gilbert Glady completed his residency in oncohematology at the University Clinic of Strasbourg. There he acquired solid experience in the management of blood diseases and already developed an interest in innovative therapeutic approaches.
Toward integrative medicine
After specializing in natural medicine in Paris, he returned to his native region to practice internal medicine in private practice. His practice gradually shifted toward integrative medicine and homeopathy, combining conventional treatments and complementary approaches. It was in this context that he deepened his expertise in immunology and immunogenetics, two fields that led him toward nanomedicine and molecular medicine.
The encounter with microRNAs
The discovery of microRNAs (miRNAs) and, later, other non-coding RNAs, represents a major turning point in his career. Considered a “highlight” of modern biology, these regulatory RNAs open new therapeutic perspectives, particularly in immunogenetics and epigenetics.
Creation of BI(G)MED and leadership of EBMA Europe
Fascinated by the potential of non-coding RNAs, Dr. Glady developed, starting in 2010, Bio Immuno(G)enetic Medicine (BI(G)MED), an innovative method for regulating genetic and epigenetic expression. He also took the helm of EBMA Europe, the association responsible for training and communication in this field.
An international figure
Dr. Glady regularly participates in international conferences (immuno-allergology, genetics, epigenetics, infectious diseases, oncology) where he presents his work in the form of posters and oral presentations. He is also the author of numerous articles published in medical and scientific journals, contributing to raising awareness of BI(G)MED and its clinical applications.
